Basel Medical (BMGL) Long-Term Deferred Tax (2024 - 2025)
Basel Medical (BMGL) posted Long-Term Deferred Tax of $36939.3 for Q4 2025, little changed sequentially from $36779.8 in Q2 2025, and down 52.03% YoY from $77005.0 in Q4 2024.
Powered by 
Analysis
Basel Medical (BMGL) Long-Term Deferred Tax (2024 - 2025) Analysis & Trends
Basel Medical has reported Long-Term Deferred Tax for 2 years, with the latest figure at $36939.3 in Q4 2025.
- Quarterly Long-Term Deferred Tax fell 52.03% year-over-year to $36939.3 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $36939.3 (down 52.03% YoY) and the FY2025 annual result came in at $36134.4, down 36.51% from the prior year.
- Long-Term Deferred Tax was little changed at $36939.3 in Q4 2025 per BMGL's latest filing, from $36779.8 in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $77005.0 in Q4 2024 and troughed at $36779.8 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 89.58 Bn | 88.57 Bn | 15.19 Bn |
| 2 | Tenet Healthcare | 22.11 Bn | 19.94 Bn | 4.45 Bn |
| 3 | Encompass Health | 12.06 Bn | 11.93 Bn | 1.34 Bn |
| 4 | Davita | 11.84 Bn | 11.16 Bn | 1.16 Bn |
| 5 | Universal Health Services | 10.13 Bn | 9.99 Bn | 3.29 Bn |
| 6 | Ensign | 9.92 Bn | 9.60 Bn | 306.24 Mn |
| 7 | Chemed | 6.89 Bn | 6.85 Bn | 221.47 Mn |
| 8 | Pacs | 6.74 Bn | 6.57 Bn | 338.46 Mn |
| 9 | Concentra Group Holdings Parent | 4.30 Bn | 4.15 Bn | 192.10 Mn |
| 10 | Basel Medical | 7.33 Mn | 6.54 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 36,939.30 |
| Jun 30, 2025 | 36,779.79 |
| Dec 31, 2024 | 77,005.00 |
| Jun 30, 2024 | 56,916.48 |